Stocks

Under the agreement, AstraZeneca will sell SZC under the brand Lokelma, while Sun Pharma will distribute it as Gimliand.

Kotak Mahindra Bank shares rise over 1% ahead of board meet to consider stock split

Kotak Mahindra Bank share gained 1.1% to Rs 2,103.10 on the NSE. It has advanced for two consecutive sessions.

Groww shares hit 20% upper circuit, extend post-listing gains to 59% in 4 sessions; m-cap reaches Rs 1.1 lakh crore

Groww shares have gained 54 percent since listing on November 12.

Kotak Mahindra Bank board to consider stock split next week

The manner of the proposed split will be decided by the board, the company said.

Mamaearth shares rise up to 9% as brokerages upbeat post-Q2 results; Jefferies sees 'glimpse of turnaround'

The company, which owns FMCG brands such as Mamaearth and The Derma Co, posted a consolidated net profit of Rs 39.22 crore for the July-September period.

Midcap index hits all-time high, smallcap index rises nearly 1%; BLS International, Biocon among key gainers

Nifty Midcap100 index hit an all-time peak, extending its winning streak to the fourth consecutive session.

IT shares gain for 3rd day: Tech Mahindra, TCS rise up to 3% on hopes of Fed rate cut, end to US shutdown

Nuvama said Indian IT companies outperformed expectations in the September quarter, with profit margins led by forex gains, operational efficiencies and robust deal-wins

Weight loss drug Wegovy to become cheaper as Novo Nordisk cuts prices by up to 37%

The company announced that the starting dose of Wegovy (0.25 mg) will now cost Rs 2,712 per week, down from Rs.4,336

Apollo Hospitals says on track for Rs 25,000-crore revenue ahead of FY27 IPO for omnichannel pharmacy & distribution arm

Backed by private equity firm Advent International, Apollo HealthCo—which combines offline pharmacy distribution, digital health services via Apollo 24/7, and the soon-to-be-merged Keimed—has seen a sharp turnaround in profitability.

Cough and cold medicine sales dip in October as syrup safety concerns mount

This marks the first time in three years that October volumes failed to surpass September, despite the onset of seasonal respiratory illnesses.

Q2 results impact: Graphite India, Epigral shares decline up to 7% on weak earnings, Krsnaa Diagnostics rises 8%

Shares of Graphite India and Epigral came under pressure on Monday.

Novo Nordisk partners with Emcure to distribute weight loss drug semaglutide in India

The partnership comes just five months after Wegovy debuted in India, and signals Novo Nordisk’s intent to scale access beyond metro cities and premium clinics.

Seven of 11 new-age listed companies continue to be loss-making in Q2FY26, but investors remain upbeat

During the July-September period, Delhivery, Swiggy, Mobikwik, Urban Company, Ixigo, BlueStone and Ola Electric, all reported losses. Some firms even saw their profit profile worsen on a YoY basis.

Cipla's Next Chapter: Achin Gupta to succeed Umang Vohra as global CEO, faces innovation challenge

Gupta, currently the Global Chief Operating Officer, will serve as MD & Global CEO-designate starting January 1, 2026. Company executives describe him as Mr Cool and no stranger to innovation and licensing deals.

Sun Pharma backs speciality play, lines up launches in US amid uncertainty over tariffs

Despite macro uncertainties, Sun Pharma has been bullish on its specialty pipeline and global expansion.

Narayana Health targets 22% RoCE by FY30 in UK bet, eyes private pay growth to boost margins

The Indian hospital chain, known for its low-cost, high-throughput model, is entering the UK market through its Cayman Islands subsidiary, acquiring the secondary care division of Practice Plus Group — the fifth-largest private healthcare network in the UK and fourth-largest NHS service provider.

Lupin stands tall in digital therapeutics as others struggle

Unlike competitors that rushed to market, Lupin spent its early years conducting trials and publishing peer-reviewed studies — a strategy that CEO Sidharth Srinivasan says has been key to survival.

Narayana Health buys UK’s Practice Plus for Rs 1,930 crore to expand global footprint

The acquisition gives Narayana Hrudayalaya a strategic entry into the mature UK healthcare market, which is witnessing a shift toward day-care procedures and increased private-pay penetration.

Cipla sees ‘material opportunity’ in Mounjaro deal, eyes deeper reach across India

The company sees no supply constraints for tirzepatide, a concern that has plagued other players in the GLP-1 space globally.

Blue Dart, Adani Green, M&M Fin rise up to 12% on strong Q2 results, positive brokerage outlook

Blue Dart shares rose 12% after it reported a 29.5% YoY rise in its second-quarter net profit, supported by rising demand for delivery services due to the festive season.

Jana Small Finance Bank declines up to 2% as RBI returns its universal bank application

RBI had granted an in-principle approval to AU Small Finance Bank for conversion into a universal bank, earlier this year.

Metal, realty shares higher on hopes of strong global demand, potential Fed rate cut

Several analysts have said that the markets have already priced in a 25 bps reduction by the US Fed, and will track the guidance on the trajectory beyond October amid chorus of further cuts in coming months.

Dr Reddy’s bets on three key launches to offset US price erosion

“Semaglutide, denosumab and abatacept are the three molecules that will help us mitigate the impact of declining Revlimid sales and bring back growth momentum,” said M.V. Narasimham, Chief Financial Officer, in a post-earnings interview.

SBI Life shares decline marginally ahead of September quarter results; here's what analysts expect

Brokerages expect the insurer to benefit from a better product mix in the second quarter.

Bharat Forge shares settle 4% higher on reports of Army order

Bharat Forge shares settled 4% higher at Rs 1,296 apiece on the NSE, after hitting an intraday high of Rs 1,311, up 5.44%.